IGNE Insider Trading Activity and SEC Form 4 Filings
IGNE insider trading summary
No open-market insider purchases or sales of Igene Biotechnology Inc (IGNE) have been reported on SEC Form 4 in the past 12 months.
Latest IGNE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 20, 2010 | Michael Kimelman | Chairman of the Board | Sell | $24K (8,000,000 @ $0.00) |
| Dec 19, 2006 | Thomas L Kempner | Director | Buy | $3K (100,000 @ $0.03) |
| Aug 17, 2006 | Thomas L Kempner | Director | Sell | $6K (150,000 @ $0.04) |
| Aug 17, 2006 | Thomas L Kempner | Director | Buy | $400 (10,000 @ $0.04) |
| Aug 17, 2006 | Thomas L Kempner | Director | Buy | $18K (450,000 @ $0.04) |
| Aug 17, 2006 | Thomas L Kempner | Director | Sell | $6K (150,000 @ $0.04) |
| Jun 28, 2006 | Thomas L Kempner | Director | Sell | $8K (200,000 @ $0.04) |
| Jun 28, 2006 | Thomas L Kempner | Director | Sell | $8K (200,000 @ $0.04) |
| Jun 15, 2006 | Thomas L Kempner | Director | Buy | $20K (500,000 @ $0.04) |
| Jun 15, 2006 | Thomas L Kempner | Director | Buy | $4K (100,000 @ $0.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.